Artal Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-200,000
Closed -$14.7M 106
2016
Q4
$14.7M Buy
+200,000
New +$14.9M 0.33% 29
2014
Q3
Sell
-200,000
Closed -$12.4M 95
2014
Q2
$12.4M Hold
200,000
0.5% 43
2014
Q1
$11.8M Sell
200,000
-400,000
-67% -$22.3M 0.43% 51
2013
Q4
$30.6M Hold
600,000
1.1% 15
2013
Q3
$30.2M Hold
600,000
0.98% 12
2013
Q2
$29.5M Buy
+600,000
New +$32.6M 0.93% 13

Other funds holding LLY

Artal Group's LLY Position: Q1 2024 in Review

Artal Group sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 1,000 shares — an estimated $583K sold.

Artal Group first reported a position in LLY in Q4 2023 and held it in 1 quarter. The position peaked at $583K in Q4 2023. 3,461 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Artal Group reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Artal Group sold 1,000 Eli Lilly shares in Q1 2024, an estimated $583K.
  • Artal Group first reported a position in Eli Lilly in Q4 2023 and held it in 1 quarter.
  • Artal Group's Eli Lilly position peaked at $583K in Q4 2023.
  • 3,461 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Artal Group's 13F filing for Q1 2024, filed 13 May 2024.